As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.
Nov 19, 2021
0
10
Individuals being treated for active cancer are at particularly high risk of severe disease and death from SARS-CoV-2 infection due to aberrant immune responses from the cancer itself and from some therapies.
Nov 10, 2021
0
127
An analysis of adults who recovered from moderate COVID-19 found that those under the age of 30 had lower neutralizing antibody levels than older people, suggesting that younger individuals may be less protected from a second ...
Nov 9, 2021
0
3
Patients with advanced breast cancer should receive COVID-19 vaccinations as soon as possible and the second dose should be delivered early, no later than three to four weeks after the first, the virtual meeting of the Advanced ...
Nov 5, 2021
0
18
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive ...
Nov 2, 2021
0
47
Monoclonal antibodies protected aged, diabetic rhesus macaque monkeys from disease due to SARS-CoV-2 and reduced signs of inflammation, including in cerebrospinal fluid, according to a new study from researchers at the University ...
Nov 1, 2021
0
94
(HealthDay)—For patients receiving dialysis who are fully vaccinated against COVID-19, the prevalence of no or diminished response varies by vaccine type and is higher with the attenuated adenovirus Ad26.COV2.S vaccine, ...
Oct 27, 2021
0
2
Suicidal thoughts, "paranoia-like fears," delusions and "foggy brain" have been identified in three adolescents who had mild or asymptomatic COVID-19. Now, a new study into their immune responses identifies a potential mechanism ...
Oct 25, 2021
1
485
US biotech firm Moderna said Monday its COVID vaccine was safe and produced a strong immune response in children aged 6-11, adding it would submit trial data to global regulators soon.
Oct 25, 2021
0
4
A new study indicates that the two-dose immunization schedule for COVID-19 mRNA vaccines ultimately stimulates comparable antibody responses in pregnant, lactating, and nonpregnant women of reproductive age, but key antibody ...
Oct 19, 2021
0
94
